Annual report pursuant to Section 13 and 15(d)

Restatement of Previously Issued Annual Consolidated Financial Statements for the Fiscal Years Ended December 31, 2022 and December 31, 2021

v3.23.3
Restatement of Previously Issued Annual Consolidated Financial Statements for the Fiscal Years Ended December 31, 2022 and December 31, 2021
12 Months Ended
Dec. 31, 2022
Accounting Changes and Error Corrections [Abstract]  
Restatement of Previously Issued Annual Consolidated Financial Statements for the Fiscal Years Ended December 31, 2022 and December 31, 2021 Restatement of Previously Issued Annual Consolidated Financial Statements for the Fiscal Years Ended December 31, 2022 and December 31, 2021
Subsequent to the issuance of the Company's consolidated financial statements as of and for the year ended December 31, 2022, included in the Form 10-K filed with the SEC on March 10, 2023, the following errors were identified:
The Company has historically recorded the re-acquired Regional Developer Rights as an intangible asset and amortized the re-acquired Regional Developer Rights over the contractual terms under the RD Agreement remaining at the time of the re-acquisition. The Company has concluded that this treatment was incorrect in accordance with U.S. GAAP. The Company should not have capitalized the re-acquired Regional Developer Rights but instead should have recognized the full cost of the re-acquisition as an expense in the respective period.
The Company has historically recorded the upfront fee paid by the regional developer as a deferred liability, which was then recognized ratably to revenue as the regional developer performed various service obligations. However, the Company concluded that the deferred liability should be ratably recognized against cost of revenue as an offset against future commissions instead of revenue.
The Company has historically charged the VIEs a management fee for the benefit of the Company providing non-clinical administrative services needed by the professional corporation chiropractic practice. The economic compensation or profitability resulting from an intercompany transaction between two or more parties is based on each party’s relative contribution to the economic activity under analysis. The standalone professional corporations have not historically been profitable from an income tax perspective and are fully valuing their deferred tax assets and related attributes for ASC 740 purposes. The professional corporations' earned annual losses were not consistent with their function, risk, and asset profile for transfer pricing. As such, the Company has estimated transfer pricing adjustments which were computed based on assumed targets of profitability. The resulting operating profit, after incorporating estimated transfer pricing adjustments, were further used as a means for computing overall potential tax exposure and correlative benefit.
The Company assessed the impact of these errors on its previously issued financial statements and determined them to be quantitatively and qualitatively material to 2022 and 2021 based on its analysis of Staff Accounting Bulletin (“SAB”) No. 99, “Materiality,” and SAB No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements”. These errors have been corrected in the accompanying consolidated balance sheets as of December 31, 2022 and 2021 and the consolidated income statements, statements of changes in stockholders’ equity, and statements of cash flows for the years then ended.
The following table summarizes the effect of the errors on the Company’s consolidated balance sheet as of December 31, 2022:
December 31,
2022
December 31,
2022
As Previously Reported
Adjustments
As Restated
Intangible assets, net $ 12,867,529  $ (1,939,234) $ 10,928,295 
Deferred tax assets
8,441,713  3,486,439  11,928,152 
Total assets 91,943,172  1,547,205  93,490,377 
Current liabilities:
Deferred franchise and regional development fee revenue, current portion 2,955,851  (2,955,851) — 
Deferred franchise fee revenue, current portion
—  2,468,601  2,468,601 
Upfront regional developer fees, current portion
—  487,250  487,250 
Other current liabilities
499,250  98,044  597,294 
Total current liabilities 23,118,973  98,044  23,217,017 
Deferred franchise and regional development fee revenue, net of current portion 15,661,412  (15,661,412) — 
Deferred franchise fee revenue, net of current portion
—  14,161,134  14,161,134 
Upfront regional developer fees, net of current portion
—  1,500,278  1,500,278 
Other liabilities
27,230  1,260,649  1,287,879 
Total liabilities 59,543,841  1,358,693  60,902,534 
Accumulated deficit (12,341,892) 188,512  (12,153,380)
Total The Joint Corp. stockholders' equity 32,374,331  188,512  32,562,843 
Total equity 32,399,331  188,512  32,587,843 
Total liabilities and stockholders' equity 91,943,172  1,547,205  93,490,377 
The following table summarizes the effect of the errors on the Company’s consolidated income statement for the year ended December 31, 2022:
Year Ended December 31,
2022
Year Ended December 31,
2022
As Previously Reported
Adjustments
As Restated
Revenues:
Regional developer fees $ 659,099  $ (659,099) $ — 
Total revenues 101,911,409  (659,099) 101,252,310 
Cost of revenues:
Franchise and regional developer cost of revenues 8,462,503  (659,099) 7,803,404 
Total cost of revenues 9,830,162  (659,099) 9,171,063 
Depreciation and amortization 7,643,980  (997,358) 6,646,622 
General and administrative expenses 67,987,482  2,245,965  70,233,447 
Total selling, general and administrative expenses 89,594,171  1,248,607  90,842,778 
Income from operations 2,076,861  (1,248,607) 828,254 
Income before income tax expense (benefit) 1,943,760  (1,248,607) 695,153 
Income tax expense (benefit) 766,510  (698,062) 68,448 
Net income 1,177,250  (550,545) 626,705 
Earnings per share:
Basic earnings per share $ 0.08  $ (0.04) $ 0.04 
Diluted earnings per share $ 0.08  $ (0.04) $ 0.04 
The following table summarizes the effect of the errors on the Company’s consolidated statements of stockholders' equity as of December 31, 2022, December 31, 2021, and December 31, 2020:
Accumulated
Deficit
Total The Joint Corp. stockholder's equity
Total Equity
12/31/2020 (as previously reported)
(20,094,912) 21,126,152  21,126,252 
Adjustment due to cumulative error correction
(250,220) (250,220) (250,220)
12/31/2020 (as restated)
(20,345,132) 20,875,932  20,876,032 
12/31/2021 (as previously reported)
(13,519,142) 29,544,627  29,569,627 
Adjustment due to cumulative error correction
739,057  739,057  739,057 
12/31/2021 (as restated)
(12,780,085) 30,283,684  30,308,684 
12/31/2022 (as previously reported)
(12,341,892) 32,374,331  32,399,331 
Adjustment due to cumulative error correction
188,512  188,512  188,512 
12/31/2022 (as restated)
(12,153,380) 32,562,843  32,587,843 
The following table summarizes the effect of the errors on the Company’s consolidated statement of cash flows for the year ended December 31, 2022:
Year Ended December 31,
2022
Year Ended December 31,
2022
As Previously Reported
Adjustments
As Restated
Cash flows from operating activities:
Net income $ 1,177,250  (550,545) $ 626,705 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 7,643,980  (997,358) 6,646,622 
Deferred income taxes 746,921  (1,188,274) (441,353)
Changes in operating assets and liabilities:
Upfront regional developer fees
—  (1,288,134) (1,288,134)
Deferred revenue 2,230,041  659,098  2,889,139 
Other liabilities
409,938  490,213  900,151 
Net cash provided by operating activities 11,084,584  (2,875,000) 8,209,584 
Cash flows from investing activities:
Reacquisition and termination of regional developer rights (2,875,000) 2,875,000  — 
Net cash used in investing activities (20,775,115) 2,875,000  (17,900,115)
Decrease in cash
(9,361,921) —  (9,361,921)
The following table summarizes the effect of the errors on the Company’s consolidated balance sheet as of December 31, 2021:
December 31,
2021
December 31,
2021
As Previously Reported
Adjustments
As Restated
Intangible assets, net 5,403,390  (690,627) 4,712,763 
Deferred tax assets
9,188,634  2,298,165  11,486,799 
Total assets 85,454,209  1,607,538  87,061,747 
Current liabilities:
Deferred franchise and regional development fee revenue, current portion 3,191,892  (3,191,892) — 
Deferred franchise fee revenue, current portion
—  2,421,721  2,421,721 
Upfront regional developer fees, current portion
—  770,171  770,171 
Other current liabilities
539,500  —  539,500 
Total current liabilities 21,438,399  —  21,438,399 
Deferred franchise and regional development fee revenue, net of current portion 15,458,921  (15,458,921) — 
Deferred franchise fee revenue, net of current portion
—  12,953,430  12,953,430 
Upfront regional developer fees, net of current portion
—  2,505,491  2,505,491 
Other liabilities
27,230  868,481  895,711 
Total liabilities 55,884,582  868,481  56,753,063 
Accumulated deficit (13,519,142) 739,057  (12,780,085)
Total The Joint Corp. stockholders' equity 29,544,627  739,057  30,283,684 
Total equity 29,569,627  739,057  30,308,684 
Total liabilities and stockholders' equity 85,454,209  1,607,538  87,061,747 
The following table summarizes the effect of the errors on the Company’s consolidated income statement for the year ended December 31, 2021:

Year Ended December 31, 2021 Year Ended December 31, 2021
As Previously Reported
Adjustments
As Restated
Revenues:
Regional developer fees 848,640  (848,640) — 
Total revenues 80,859,653  (848,640) 80,011,013 
Cost of revenues:
Franchise and regional developer cost of revenues 7,408,125  (848,639) 6,559,486 
Total cost of revenues 8,513,777  (848,639) 7,665,138 
Depreciation and amortization 6,088,947  (2,167,060) 3,921,887 
General and administrative expenses 49,453,305  1,393,513  50,846,818 
Total selling, general and administrative expenses 66,966,668  (773,547) 66,193,121 
Income from operations 5,352,419  773,546  6,125,965 
Income before income tax expense (benefit) 5,282,541  773,546  6,056,087 
Income tax (benefit)
(1,293,229) (215,731) (1,508,960)
Net income 6,575,770  989,277  7,565,047 
Earnings per share:
Basic earnings per share $ 0.46  $ 0.07  $ 0.53 
Diluted earnings per share $ 0.44  $ 0.07  $ 0.51 
The following table summarizes the effect of the errors on the Company’s consolidated statement of cash flows for the year ended December 31, 2021:
Year Ended December 31, 2021 Year Ended December 31, 2021
As Previously Reported
Adjustments
As Restated
Cash flows from operating activities:
Net income $ 6,575,770  989,277  $ 7,565,047 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 6,088,947  (2,167,060) 3,921,887 
Deferred income taxes
(1,247,199) (530,958) (1,778,157)
Changes in operating assets and liabilities:
Upfront regional developer fees
—  (572,944) (572,944)
Deferred revenue 3,624,944  537,265  4,162,209 
Other liabilities
1,059,507  355,720  1,415,227 
Net cash provided by operating activities 15,232,780  (1,388,700) 13,844,080 
Cash flows from investing activities:
Reacquisition and termination of regional developer rights (1,388,700) 1,388,700  — 
Net cash used in investing activities (14,143,369) 1,388,700  (12,754,669)
Decrease in cash
(907,291) —  (907,291)